{"name":"GC Biopharma Corp","slug":"gc-biopharma-corp","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"GC5107","genericName":"GC5107","slug":"gc5107","indication":"Type 2 diabetes mellitus","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"MG1111 (Barycela inj.)","genericName":"MG1111 (Barycela inj.)","slug":"mg1111-barycela-inj","indication":"Chronic hepatitis B","status":"phase_3"}]}],"pipeline":[{"name":"GC5107","genericName":"GC5107","slug":"gc5107","phase":"phase_3","mechanism":"GC5107 is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist that enhances insulin secretion and reduces glucagon release to lower blood glucose levels.","indications":["Type 2 diabetes mellitus"],"catalyst":""},{"name":"MG1111 (Barycela inj.)","genericName":"MG1111 (Barycela inj.)","slug":"mg1111-barycela-inj","phase":"phase_3","mechanism":"MG1111 is a recombinant human albumin-fused interferon alpha (IFN-α) fusion protein that enhances antiviral and immunomodulatory activity.","indications":["Chronic hepatitis B","Chronic hepatitis C"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNbkVVSzdNWUlhbkpEdERDbzhIQUk4ZlN0MkpMMjFXQk04b19FY1lkdnpiV0VKb0g3bldOT1dMUDlEZ1RLeXBSc2dCc19xMFBNSFVINUlYQTl0OVpTZGRCZzdub2RvM0lOQ212cFBGZm4tSHRiQW12VEpuOXg2SHg3djRmYUxJcjB0dGpVcDR4MEJRdUs4bFdQVEJqTkxoVHpMQmF0TEhwaFhLU2pDVEpMVi01SW56R2FYekt4d0hvWjRlZw?oc=5","date":"2026-04-06","type":"pipeline","source":"Contract Pharma","summary":"GC Biopharma Validates Proprietary Technology to Mitigate Thromboembolic Risks - Contract Pharma","headline":"GC Biopharma Validates Proprietary Technology to Mitigate Thromboembolic Risks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBQNklPdXhlb2ZaS3pRc2hCY0doS09yWkJxVE03OEZTb1QtTmV5MGYzcnJQTEUyUWdnOHg0RUZlbEJuUmNoTWFXNDBQd0hkWmk1Q0MtMGlEWHY4NENVeXBSTEQxVVRheVB1Uy1LYnJ30gFyQVVfeXFMUEViQnNBazkya3Rhd3hzWmxxRWtqZFNkMmxvUjk3MTY5OVROSl8waUh3aVB1RUpKcHNuOHUzdnVXaVF6cHJCMVVTVXVpTTgtcXRTYVpYVjc2UXZWa3V4Sm56RlN2X3A3bFJReGVWMXFTck53?oc=5","date":"2026-03-05","type":"pipeline","source":"koreabiomed.com","summary":"Korean pharma braces for governance reforms, CEO renewals in March meetings - koreabiomed.com","headline":"Korean pharma braces for governance reforms, CEO renewals in March meetings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPSjNNVUlkNmdDejFMSXBBb1hvMjZEM1k4SGhBaHVuVVF0clZHRFRoQ2tCN0t1VDZySF9EcU10aWR0S0dXeEF0T05ZWWJpYTc5eGtreEZOdFpQakk4SE1ZN0VTTzJUeTZvNlB5TzlKUDEySEhLcU91MmFLSG5NMC1zRDdCSnljMFpy?oc=5","date":"2026-02-19","type":"pipeline","source":"조선일보","summary":"Top Five Pharma Sales Jump 9%, Near 9 Trillion Won - 조선일보","headline":"Top Five Pharma Sales Jump 9%, Near 9 Trillion Won - 조선일보","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQSHBTSUxObHNGZ3FyellyQnBRUkU3emtZeGRWVzlWdWUwNHVWUlcyV2FyUUhIeE13bjRTUUh6Zm41RkpBWlZMSmpPRVJFbDZDN1dRZWRSTUc2ZUZLeW54ZDZBTnpLc0NWT0lHS25JaC1PYm95eVlLd1NFLWZKejhKdNIBlAFBVV95cUxOVlhUbEZ1Y1o2c1NXX09QemJaTnplVHlnRE5TQnRZR2Z4NGQzQTF3N1Z2WGEwQ3ZEQ3p1MDVTSTZ0ZTVybDJmbjRWQ1BBWEpCS1ZTMzZtU2ROSXBpVWI3XzRNOTBRQmg5VzhnOFFXbzRldm9GQnFOclBrWnNDd2xyeDJkUl9ZLUtkTGI5eE96TE1xeXdM?oc=5","date":"2025-10-22","type":"earnings","source":"Chosunbiz","summary":"Korean pharma firms show mixed Q3 results as Samsung Biologics and Celltrion drive record sales and profits - CHOSUNBIZ - Chosunbiz","headline":"Korean pharma firms show mixed Q3 results as Samsung Biologics and Celltrion drive record sales and profits - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPVlo0UlJ3YmZfN1Foa3J1end3NHMyb0hXekVqQ0h3X2l6SVFwcnZlQkdGNXhqZzFGZWMwTUxxZkU5QTBZcUNGNDRheUIxWWVkMkZySm9qMXU0bnVadmVaMGRHdEF6RjU3SDJWM0VqNWQyaUJlUkNWY3puLUNIb1pSbk1HZEtBZFNkdmlkN1EzTmM4bjFkNkFpRHc0NjlZRnpWMDE1VGhkUzg?oc=5","date":"2025-06-17","type":"deal","source":"BioWorld News","summary":"Korea biotech roundup: four financings, six R&D deals mid-June - BioWorld News","headline":"Korea biotech roundup: four financings, six R&D deals mid-June","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9jaW5tZTVtdldDMTlNTm41RGdhcGpkTzY5Nk1GLWYxN0ItRnpCTzhqNDQ1RkRBLTdtVHJBdUZjRGhqQldLclRiRGlPaDdwbU5vNGc5dHlKM0h5aFFDaXJOc3JPMFlFUG8wYkFXb3lB0gFyQVVfeXFMTWlUcklMSFRSTXIwS3NrSzNSU3BZLUUwZFNhMlp0bjhXcnJhcFZwbjZhTnhiVVlkYlI2ekJGLTdMVmpUTXk2LW9NdGdmTlBxZmRWNC1FWVctTWt6bnM3bzJhWGJydTF3T3l1MlA0XzFYOWpB?oc=5","date":"2025-05-26","type":"pipeline","source":"koreabiomed.com","summary":"GC Biopharma secures largest share of Korea's national flu vaccine bid - koreabiomed.com","headline":"GC Biopharma secures largest share of Korea's national flu vaccine bid","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBZMXduWjNKbng1dUE5VnpKRzFfd2pIb0F4SUMybWpIRkk5QzNtb3pDWC1IUktJRWNTQ1owM0JFWHJwY0ZGQUR5Wm9kejNJdC1LZmFjT3U0Rk1jVDRON1lTX2haeDJHcFN1cThQRUxR0gFyQVVfeXFMUEdQdWJSMG1xRndVRUxmYlFqNEVTeXdOd2laZ1NtQXZ2YzB2UkQzZThSV0JRZUpoMWVBaXRTcWxoR2l2WFNMcWVqcmt4VmlhQXZINUktVTZPZU5QNmYwT19sU0JCQjY4R205TTdrRGFpOXhB?oc=5","date":"2025-04-23","type":"pipeline","source":"koreabiomed.com","summary":"GC Biopharma secures record flu vaccine bid in Thailand - koreabiomed.com","headline":"GC Biopharma secures record flu vaccine bid in Thailand","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxOX1VBRnZyYVJiSGd1WHlkS2tMZnJLQllneDlnZldtakN1Qk9ZR0g0aU1NS1ZlY0FjYmFBa2lPX0xGaE9BcEptaGEwY1A0UkYwamNMSkRmSDl0aXNkb3dwd0wxbDBaOEUya0lycjg1VFZROFhvd1pUbDAyaVdVU2dVTnNsamUzT3AxZXlEUUZhVzR1VFk5VzV0VE50VW5fWmFvMXFjcnNHbURsTmZDbkFURmVHeGF1OHczNVF5UHNtM3lQZUxvdXVJSU0zdkFGNU1icmhJMWxZNGNRM0ptemc?oc=5","date":"2024-11-26","type":"trial","source":"BioSpace","summary":"GC Biopharma and Novel Pharma First Patient Dosed in Global Phase I Clinical Trial for MPS IIIA Treatment - BioSpace","headline":"GC Biopharma and Novel Pharma First Patient Dosed in Global Phase I Clinical Trial for MPS IIIA Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNclBVZ0lud280ZEJubWIzRkdJanNET2RJMDR2NVl5R0o4NnlKaTF5cVQ0Z2ZpdlpnNjdXTGZiVW5ZUUg0a2c4Yk96UUkxbWpDZERWOWswMmNPSzY0U2NOSmk2aWxlNGtzS1NneV9PRm9uUkxpb2wtRGtvVENZbElKVHRBTmxmZ29ZVkpOUWJFZHNTLWpudUZCQ0dHYllpclNkbUc3cFlwTXdPMWJpYlo5Q2piWmxDdUtEc1lxY3M3Q3hzOHBBbm5McnFNVjJ1S3ZxektmTnQ4RGtXbG5NdDNN?oc=5","date":"2024-09-03","type":"regulatory","source":"BioSpace","summary":"GC Biopharma and Hanmi Pharmaceutical Receives IND Clearance for Phase 1/2 Clinical Trial from the U.S. FDA - BioSpace","headline":"GC Biopharma and Hanmi Pharmaceutical Receives IND Clearance for Phase 1/2 Clinical Trial from the U.S. FDA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBjNW1DUXBnd2RJdnB6eEFXVGM1RHhTRU51VFctR3JxWS1McUE4WmpVRHVOelpOOVkycGFIVVI2cFZIMzBZZVI2bUNLNVVZRlNjOFI2cXVqVk13dWF1RHlhVGZmYkw1cmFLeWNPV09R?oc=5","date":"2024-07-18","type":"pipeline","source":"KED Global","summary":"GC Biopharma sells HK subsidiary to CR Pharm Group for $254 mn - KED Global","headline":"GC Biopharma sells HK subsidiary to CR Pharm Group for $254 mn","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE40Xy1rQ0hPTzREcEdRVUVxTXpWeGJqMzNXcEpCVmpYU0tZSU9uWXdrb2FrZGdUcDJvdENLRUpiMXVnbDJXYUh2eDNTdHlhN0dnWERaUmEtZW13QjFZaVZvc0xtUmduWjhKa3NWTW9R?oc=5","date":"2024-02-28","type":"pipeline","source":"KED Global","summary":"GC Biopharma aims to boost Alyglo sales sixfold in the US - KED Global","headline":"GC Biopharma aims to boost Alyglo sales sixfold in the US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNbm9WTFNXZ2F2dVRPQlotdFdLTjY2b1FhSUlJZ3MtRW1lS0g2T3R1bHRKdFY5TjR1ZEpLbFBiTFZxQW9XdG5pTHdDMHV4U3I5SjR4S0x2Ni05WnA1aDA4Z2R5MG94WXV6MnBWaFgtQ2RuWW9BcU5CUHdOUEFsLU85UmhpNy1Pcjd4QzE0UkNjblF1dnlSMFRSdUJpX3otcTlk?oc=5","date":"2022-03-29","type":"pipeline","source":"Business Wire","summary":"GC Pharma Changes Its Name to “GC Biopharma” - Business Wire","headline":"GC Pharma Changes Its Name to “GC Biopharma”","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}